Marker Therapeutics (MRKR) EBITDA (2011 - 2023)
Marker Therapeutics (MRKR) reported EBITDA of -$3.49 million for Q1 2023, compared with -$9.22 million a year earlier.
Powered by 
Analysis
Marker Therapeutics (MRKR) EBITDA (2011 - 2023) Analysis & Trends
Over the twelve months ended Mar 31, 2023, Marker Therapeutics' EBITDA came in at -$15.41 million; for FY2022, it came in at -$17 million.
- By year, EBITDA came in at -$37.33 million in FY2021, -$28.4 million in FY2020, -$22.42 million in FY2019 and -$148.17 million in FY2018.
- Five-year quarterly EBITDA spans a low of -$10.38 million in Q2 2021 and a high of -$2.23 million in Q4 2022.
- Per Business Quant data, the three quarters before Q1 2023 came in at -$2.23 million (Q4 2022), -$5.01 million (Q3 2022) and -$4.69 million (Q2 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Marker Therapeutics | 17.87 Mn | -42.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | -3.49 Mn |
| Dec 31, 2022 | -2.23 Mn |
| Sep 30, 2022 | -5.01 Mn |
| Jun 30, 2022 | -4.69 Mn |
| Mar 31, 2022 | -9.22 Mn |
| Dec 31, 2021 | -9.20 Mn |
| Sep 30, 2021 | -9.47 Mn |
| Jun 30, 2021 | -10.38 Mn |
| Mar 31, 2021 | -8.28 Mn |
| Dec 31, 2020 | -8.30 Mn |
| Sep 30, 2020 | -7.23 Mn |
| Jun 30, 2020 | -6.27 Mn |
| Mar 31, 2020 | -6.61 Mn |
| Dec 31, 2019 | -5.33 Mn |
| Sep 30, 2019 | -5.62 Mn |
| Jun 30, 2019 | -5.84 Mn |
| Mar 31, 2019 | -5.63 Mn |
| Sep 30, 2018 | -4.43 Mn |
| Jun 30, 2018 | -4.67 Mn |
| Mar 31, 2018 | -3.20 Mn |
API Access
Marker Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=MRKR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "MRKR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=MRKR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();